Namenda Teaching 1955
SN instructed patient on new medication Namenda. SN instructed patient that namenda extended-release capsules are approved for the treatment of moderate to severe Alzheimer's disease, and that the most common side effects associated with namenda treatment are headache, diarrhea, and dizziness. Understanding was verbalized
Reviewed November 2017
Reviewed for general reference only. Adapt to your patient, agency policy, and scope of practice.